We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
Survival analysis data not available.
LUNG ADENOCARCINOMA - Protein relative expression (CPTAC)
Number of samples
213
Samples
Sample ID
Sample type
nRPX
CPT0011750003
Normal
1.0
CPT0110980004
Tumor
0.9
CPT0084140003
Tumor
0.8
CPT0014930003
Normal
0.8
CPT0008420003
Normal
0.7
CPT0021490003
Normal
0.7
CPT0146980004
Tumor
0.7
CPT0090600003
Normal
0.7
CPT0114880003
Normal
0.7
CPT0147100003
Normal
0.7
CPT0066810003
Normal
0.6
CPT0090200003
Normal
0.6
CPT0021450003
Tumor
0.6
CPT0068100003
Tumor
0.6
CPT0118650003
Normal
0.6
CPT0106110003
Tumor
0.6
CPT0083810003
Normal
0.6
CPT0001810003
Normal
0.6
CPT0001960003
Tumor
0.6
CPT0092940003
Normal
0.6
CPT0118010003
Normal
0.6
CPT0106100003
Normal
0.5
CPT0011910004
Tumor
0.5
CPT0090170004
Tumor
0.5
CPT0097600003
Normal
0.5
CPT0069720003
Normal
0.5
CPT0001660013
Tumor
0.5
CPT0001390003
Normal
0.5
CPT0070060003
Tumor
0.5
CPT0001800013
Tumor
0.5
CPT0082740004
Tumor
0.5
CPT0114690003
Normal
0.4
CPT0110890003
Normal
0.4
CPT0082770003
Normal
0.4
CPT0105680003
Normal
0.4
CPT0011930003
Normal
0.4
CPT0062810003
Normal
0.4
CPT0067250003
Tumor
0.4
CPT0092930003
Tumor
0.4
CPT0110860004
Tumor
0.3
CPT0067290003
Normal
0.3
CPT0001070003
Normal
0.3
CPT0090370003
Normal
0.3
CPT0113990003
Tumor
0.3
CPT0067950003
Normal
0.3
CPT0001690003
Normal
0.3
CPT0013910003
Normal
0.3
CPT0090340003
Tumor
0.3
CPT0070080003
Normal
0.3
CPT0013880003
Tumor
0.3
CPT0023310003
Tumor
0.3
CPT0011710004
Tumor
0.3
CPT0001970003
Normal
0.3
CPT0118830003
Normal
0.3
CPT0008410003
Tumor
0.3
CPT0113220003
Normal
0.3
CPT0090700003
Tumor
0.3
CPT0118360003
Normal
0.3
CPT0090720003
Normal
0.2
CPT0118340003
Tumor
0.2
CPT0115070003
Tumor
0.2
CPT0105940003
Tumor
0.2
CPT0109760003
Normal
0.2
CPT0112060003
Tumor
0.2
CPT0105610003
Normal
0.2
CPT0105980003
Normal
0.2
CPT0105060003
Tumor
0.2
CPT0097580003
Tumor
0.2
CPT0148000003
Normal
0.2
CPT0112080003
Normal
0.2
CPT0023320003
Normal
0.2
CPT0086320003
Normal
0.2
CPT0066890003
Tumor
0.2
CPT0105710003
Tumor
0.2
CPT0014290003
Normal
0.2
CPT0147080004
Tumor
0.2
CPT0105600003
Tumor
0.2
CPT0147500003
Normal
0.1
CPT0086770003
Normal
0.1
CPT0082850004
Tumor
0.1
CPT0105370004
Normal
0.1
CPT0091260003
Normal
0.1
CPT0109710003
Normal
0.1
CPT0083140003
Normal
0.1
CPT0069520003
Tumor
0.1
CPT0001590003
Normal
0.1
CPT0148200003
Normal
0.1
CPT0118180003
Normal
0.1
CPT0111300003
Tumor
0.1
CPT0118600003
Normal
0.1
CPT0092530003
Tumor
0.1
CPT0090900004
Normal
0.1
CPT0118810003
Tumor
0.1
CPT0115090003
Normal
0.1
CPT0068650003
Normal
0.1
CPT0090570004
Tumor
0.1
CPT0055100004
Tumor
0.1
CPT0125830003
Normal
0.1
CPT0146700003
Normal
0.1
CPT0068830003
Normal
0.0
CPT0091860003
Tumor
0.0
CPT0114010003
Normal
0.0
CPT0118160003
Tumor
0.0
CPT0109850003
Normal
0.0
CPT0066930003
Normal
0.0
CPT0067110003
Normal
0.0
CPT0069550003
Normal
0.0
CPT0105190003
Normal
0.0
CPT0051690004
Tumor
0.0
CPT0117970003
Tumor
0.0
CPT0013630003
Normal
0.0
CPT0084170003
Normal
0.0
CPT0114660004
Tumor
0.0
CPT0079850003
Normal
0.0
CPT0147400003
Normal
0.0
CPT0079830003
Tumor
0.0
CPT0052940004
Tumor
0.0
CPT0001060010
Tumor
0.0
CPT0146800003
Normal
0.0
CPT0147000003
Normal
0.0
CPT0105250003
Normal
0.0
CPT0111590003
Normal
-0.1
CPT0104650003
Normal
-0.1
CPT0063750003
Normal
-0.1
CPT0089340003
Tumor
-0.1
CPT0052170004
Tumor
-0.1
CPT0148100003
Normal
-0.1
CPT0067940003
Tumor
-0.1
CPT0083780003
Tumor
-0.1
CPT0105740003
Normal
-0.1
CPT0102480003
Normal
-0.1
CPT0102450003
Tumor
-0.1
CPT0105010004
Normal
-0.1
CPT0147480004
Tumor
-0.1
CPT0000930003
Normal
-0.1
CPT0105550003
Normal
-0.1
CPT0148300003
Normal
-0.1
CPT0146600003
Normal
-0.1
CPT0067470004
Normal
-0.2
CPT0109720004
Tumor
-0.2
CPT0148180004
Tumor
-0.2
CPT0104760003
Normal
-0.2
CPT0068130003
Normal
-0.2
CPT0109700003
Normal
-0.2
CPT0147600003
Normal
-0.2
CPT0104630003
Tumor
-0.2
CPT0092250003
Normal
-0.2
CPT0118620003
Tumor
-0.2
CPT0109740004
Tumor
-0.2
CPT0147580004
Tumor
-0.2
CPT0067070003
Tumor
-0.2
CPT0105330003
Tumor
-0.2
CPT0069700003
Tumor
-0.2
CPT0118200003
Tumor
-0.2
CPT0091870003
Normal
-0.2
CPT0067770003
Normal
-0.2
CPT0147380004
Tumor
-0.2
CPT0063840003
Normal
-0.2
CPT0098130003
Tumor
-0.2
CPT0000920017
Tumor
-0.2
CPT0125810003
Tumor
-0.2
CPT0105510003
Tumor
-0.2
CPT0118890003
Normal
-0.2
CPT0114840003
Tumor
-0.3
CPT0001380003
Tumor
-0.3
CPT0111480003
Normal
-0.3
CPT0104750003
Tumor
-0.3
CPT0069370003
Normal
-0.3
CPT0147900003
Normal
-0.3
CPT0063730003
Tumor
-0.3
CPT0086310003
Tumor
-0.3
CPT0083420003
Normal
-0.3
CPT0089360003
Normal
-0.3
CPT0104970003
Tumor
-0.3
CPT0068610003
Tumor
-0.3
CPT0082890003
Normal
-0.4
CPT0118240003
Normal
-0.4
CPT0083100003
Tumor
-0.4
CPT0105270003
Tumor
-0.4
CPT0091240003
Tumor
-0.4
CPT0146680004
Tumor
-0.4
CPT0015420003
Normal
-0.4
CPT0069360003
Tumor
-0.4
CPT0014860003
Tumor
-0.4
CPT0105630003
Tumor
-0.4
CPT0090860003
Tumor
-0.4
CPT0068800003
Tumor
-0.4
CPT0015410003
Tumor
-0.4
CPT0092240003
Tumor
-0.5
CPT0008450003
Tumor
-0.5
CPT0067620003
Tumor
-0.5
CPT0113210003
Tumor
-0.5
CPT0147980004
Tumor
-0.5
CPT0118570003
Tumor
-0.5
CPT0063810003
Tumor
-0.6
CPT0109830004
Tumor
-0.6
CPT0109680004
Tumor
-0.6
CPT0147880004
Tumor
-0.6
CPT0118880003
Tumor
-0.6
CPT0001580009
Tumor
-0.6
CPT0066780003
Tumor
-0.7
CPT0146880004
Tumor
-0.7
CPT0053040004
Tumor
-0.7
CPT0086750003
Tumor
-0.7
CPT0146780004
Tumor
-0.8
CPT0013600003
Tumor
-0.8
CPT0148280004
Tumor
-0.8
CPT0083390004
Tumor
-0.9
CPT0014260003
Tumor
-0.9
CPT0067450003
Tumor
-1.0
CPT0105230003
Tumor
-1.1
CPT0146580004
Tumor
N/A
CPT0148080004
Tumor
N/A
Show allShow less
LUNG SQUAMOUS CELL CARCINOMA - Protein relative expression (CPTAC)
Number of samples
212
Samples
Sample ID
Sample type
nRPX
CPT0136640003
Tumor
1.3
CPT0023470003
Tumor
1.0
CPT0221220003
Normal
0.9
CPT0175260003
Tumor
0.9
CPT0202580004
Normal
0.9
CPT0130030003
Tumor
0.8
CPT0187370003
Tumor
0.8
CPT0245780003
Tumor
0.8
CPT0105430003
Normal
0.7
CPT0091610003
Tumor
0.7
CPT0197090003
Tumor
0.7
CPT0202350004
Tumor
0.7
CPT0218280003
Tumor
0.7
CPT0112580003
Tumor
0.6
CPT0197150003
Tumor
0.6
CPT0069900003
Normal
0.6
CPT0091820003
Tumor
0.6
CPT0087210003
Normal
0.6
CPT0104380003
Normal
0.6
CPT0195520003
Normal
0.6
CPT0197860003
Normal
0.6
CPT0227070003
Normal
0.6
CPT0202400004
Normal
0.5
CPT0219390003
Normal
0.5
CPT0191710003
Tumor
0.5
CPT0197380003
Normal
0.5
CPT0192590004
Normal
0.5
CPT0237690004
Tumor
0.5
CPT0108560003
Tumor
0.5
CPT0098800003
Normal
0.5
CPT0175560003
Tumor
0.4
CPT0007740003
Tumor
0.4
CPT0186180003
Tumor
0.4
CPT0221200003
Tumor
0.4
CPT0217420003
Tumor
0.4
CPT0023500003
Normal
0.4
CPT0192540004
Tumor
0.4
CPT0079100003
Tumor
0.4
CPT0130310003
Normal
0.4
CPT0128900003
Normal
0.4
CPT0102840003
Normal
0.3
CPT0128890003
Tumor
0.3
CPT0063500003
Normal
0.3
CPT0117720003
Tumor
0.3
CPT0236420003
Tumor
0.3
CPT0209510003
Normal
0.3
CPT0079050003
Tumor
0.3
CPT0091050003
Tumor
0.3
CPT0197740003
Tumor
0.3
CPT0237990003
Normal
0.3
CPT0197520003
Normal
0.3
CPT0147700003
Normal
0.3
CPT0234950004
Normal
0.3
CPT0091090003
Normal
0.3
CPT0117770003
Normal
0.3
CPT0237060004
Tumor
0.3
CPT0010050003
Tumor
0.3
CPT0222740003
Normal
0.3
CPT0202720003
Tumor
0.3
CPT0241210003
Normal
0.3
CPT0233160003
Normal
0.3
CPT0227400003
Tumor
0.3
CPT0197170003
Normal
0.3
CPT0196810003
Tumor
0.3
CPT0126470003
Normal
0.3
CPT0237970004
Tumor
0.3
CPT0183270003
Normal
0.2
CPT0086260003
Tumor
0.2
CPT0010060003
Normal
0.2
CPT0217490003
Normal
0.2
CPT0112600003
Normal
0.2
CPT0191930003
Normal
0.2
CPT0146400003
Normal
0.2
CPT0209040003
Normal
0.2
CPT0007760003
Normal
0.2
CPT0089880003
Tumor
0.2
CPT0147180004
Tumor
0.2
CPT0237710003
Normal
0.2
CPT0112550003
Normal
0.2
CPT0197210003
Tumor
0.1
CPT0245880003
Tumor
0.1
CPT0126810003
Tumor
0.1
CPT0086270003
Normal
0.1
CPT0241170003
Tumor
0.1
CPT0175270003
Normal
0.1
CPT0136660003
Normal
0.1
CPT0108600003
Normal
0.1
CPT0236430003
Normal
0.1
CPT0186210003
Normal
0.1
CPT0104930003
Tumor
0.1
CPT0245890003
Normal
0.1
CPT0234790003
Tumor
0.1
CPT0222730003
Tumor
0.1
CPT0237430003
Normal
0.1
CPT0001030003
Normal
0.1
CPT0223820003
Normal
0.1
CPT0202530004
Tumor
0.1
CPT0232670003
Tumor
0.1
CPT0205000003
Normal
0.1
CPT0202740003
Normal
0.1
CPT0091620003
Normal
0.1
CPT0197100003
Normal
0.1
CPT0112650003
Tumor
0.1
CPT0126390003
Tumor
0.1
CPT0112660003
Normal
0.1
CPT0227420003
Normal
0.1
CPT0245840003
Normal
0.0
CPT0208780003
Normal
0.0
CPT0234820003
Normal
0.0
CPT0234580003
Normal
0.0
CPT0126760003
Normal
0.0
CPT0237080003
Normal
0.0
CPT0104950003
Normal
0.0
CPT0209020004
Tumor
0.0
CPT0234560003
Tumor
0.0
CPT0233330003
Normal
0.0
CPT0232690003
Normal
0.0
CPT0191750003
Normal
0.0
CPT0123350003
Tumor
0.0
CPT0126830003
Normal
0.0
CPT0197480003
Tumor
0.0
CPT0115860003
Normal
0.0
CPT0219360003
Tumor
0.0
CPT0221660003
Normal
0.0
CPT0191860003
Tumor
0.0
CPT0175160003
Normal
0.0
CPT0063430003
Tumor
0.0
CPT0245790003
Normal
0.0
CPT0175390003
Tumor
0.0
CPT0126740003
Tumor
-0.1
CPT0063440003
Normal
-0.1
CPT0237780003
Normal
-0.1
CPT0001020003
Tumor
-0.1
CPT0186130003
Tumor
-0.1
CPT0147200003
Normal
-0.1
CPT0186140003
Normal
-0.1
CPT0083990003
Normal
-0.1
CPT0126400003
Normal
-0.1
CPT0204660003
Normal
-0.1
CPT0196820003
Normal
-0.1
CPT0130440004
Normal
-0.1
CPT0098770003
Tumor
-0.1
CPT0204990003
Tumor
-0.1
CPT0218310003
Normal
-0.1
CPT0187380003
Normal
-0.1
CPT0202170003
Tumor
-0.1
CPT0068320003
Normal
-0.1
CPT0068280003
Tumor
-0.2
CPT0237210003
Normal
-0.2
CPT0079060003
Normal
-0.2
CPT0207250003
Normal
-0.2
CPT0204820003
Normal
-0.2
CPT0204800003
Tumor
-0.2
CPT0202040003
Normal
-0.2
CPT0090440003
Tumor
-0.2
CPT0233600003
Tumor
-0.2
CPT0111000004
Normal
-0.2
CPT0102790003
Tumor
-0.2
CPT0146500003
Normal
-0.2
CPT0079110003
Normal
-0.2
CPT0245830003
Tumor
-0.2
CPT0083980003
Tumor
-0.2
CPT0130070003
Normal
-0.2
CPT0238110004
Tumor
-0.2
CPT0237410004
Tumor
-0.2
CPT0115830003
Tumor
-0.3
CPT0233640003
Normal
-0.3
CPT0105420003
Tumor
-0.3
CPT0238130003
Normal
-0.3
CPT0126450003
Tumor
-0.3
CPT0233320003
Tumor
-0.3
CPT0123370003
Normal
-0.3
CPT0101130003
Tumor
-0.3
CPT0237200004
Tumor
-0.3
CPT0112540003
Tumor
-0.3
CPT0063480003
Tumor
-0.4
CPT0130270003
Tumor
-0.4
CPT0237570003
Normal
-0.4
CPT0225470003
Normal
-0.4
CPT0064050003
Normal
-0.4
CPT0209490003
Tumor
-0.4
CPT0104360003
Tumor
-0.4
CPT0234930004
Tumor
-0.4
CPT0221650003
Tumor
-0.4
CPT0202020008
Tumor
-0.5
CPT0208770003
Tumor
-0.5
CPT0195510003
Tumor
-0.5
CPT0175410003
Normal
-0.5
CPT0202220004
Normal
-0.5
CPT0233120003
Tumor
-0.5
CPT0130410003
Tumor
-0.5
CPT0087190003
Tumor
-0.5
CPT0204600003
Tumor
-0.5
CPT0190550003
Tumor
-0.6
CPT0207210003
Tumor
-0.6
CPT0112730003
Normal
-0.6
CPT0225380003
Tumor
-0.6
CPT0183250004
Tumor
-0.6
CPT0175120003
Tumor
-0.6
CPT0146380004
Tumor
-0.7
CPT0146480004
Tumor
-0.7
CPT0223790003
Tumor
-0.8
CPT0069890003
Tumor
-0.8
CPT0112720003
Tumor
-0.9
CPT0064040003
Tumor
-1.0
CPT0237550004
Tumor
-1.0
CPT0111150004
Tumor
-1.1
CPT0126670003
Tumor
-1.1
CPT0227020003
Tumor
-1.2
CPT0147680004
Tumor
-1.3
CPT0237760003
Tumor
-1.3
CPT0126530003
Tumor
-1.9
Show allShow less
LUNG CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.
Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.